IDH2 and oligodendroglioma: Based on the latest report of the Central Brain Tumor Registry of the United States (CBTRUS) 2016–2020, the average annual age-adjusted incidence rate of IDH-mutant and 1p/19q-co-deleted oligodendroglioma is 0.29 (95% CI 0.28–0.30).